期刊文献+

甘草酸二铵注射液治疗病毒性肝炎的临床效果 被引量:2

下载PDF
导出
摘要 目的:观察甘草酸二铵注射液治疗病毒性肝炎的临床效果。方法:选取肝炎病毒传染期患者64例,采用随机数字表法分成观察组与对照组各32例。对照组采用常规治疗,观察组采用甘草酸二胺治疗,对比两组患者的临床治疗效果。结果:治疗前,两组患者ALT、AST与T-BiL指标比较,差异无统计学意义(P>0.05),治疗后观察组上述各项指标显著低于对照组,差异具有统计学意义(P<0.05);观察组治疗的有效率为93.75%,高于对照组的68.75%,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在常规治疗基础上采用甘草酸二铵治疗病毒性肝炎的临床效果优于单纯常规治疗。
作者 刘施佳
出处 《中国民康医学》 2019年第8期38-40,共3页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献8

二级参考文献54

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华传染病杂志,2011,29(1):65-80.
  • 2Zhang Z, Zhang JY, Wang LF, et al. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection [J]. J Gastroenterol Hepatol, "2012, 27(2) :223 230. DOI: 10. llll/j. 1440-1745. 2011. 06940. x.
  • 3Li J, Han Y, Jin K, et al. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B inecion [J/OL]. Viro J, 2011, 8 : I_99 (2011-05-02) [2016- 01-10]. http: // virologyi, biomedcentral, com/articles/lO. 1186/1743-422X-8-199. DOI: 10. 1186/1743-422X-8-199.
  • 4Akbar SM, Horiike N, Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection [J]. World J Gastroenterol, 2006, 12 (18) : 2876- 2883. DOI: I0. 3748/wig. v12. i18. 2876.
  • 5Boni C, Laceabue D, Lampertico P, et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues [J]. Gastroenterology, 2012,143(4) : 963-973. DOI: 10. 1053/j. gastro. 2012.07. 014.
  • 6Honkoop P, de Man RA, Niesters HG, et al. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy [J]. Hepatology, 2000, 32 (3) :635-659. DOI 10. 1053/jhep. 2000. 16333.
  • 7Carey I, DAntiga L, Bansal S,et al. Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy [J]. J Virol, 2011,85(5) 2416- 2428. DOI 10. 1128/JVI. 01449-10.
  • 8Ishikawa T. Immunoregulation of hepatitis B virus infection-- rationale and clinical application [J]. Nagoya J Med Sci, 2012, 74(3-4) 217-232.
  • 9Wang GQ, Ding YP, Dong YH. Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients [J]. J Viral Hepat, 2013, 20 Suppl 1: 9-17. DOI: 10. llll/jvh. 12059.
  • 10Cao W, Qiu ZF, Li TS. Parallel decline of CD8+ CD38+ lymphocytes and viremia in treated hepatitis B patients [J]. World J Gastroenterol, 2011,17 (17) : 2191-2198. DOI: 10. 3748/wig. v17. i17. 2191.

共引文献49

同被引文献36

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部